Infertility, Polycystic ovary syndrome.
Conditions
Interventions
Intervention 1: Intervention group: Received combination of 2000 mg and 200 micro gr Folic acid twice a day. Intervention 2: Control group: Received 500 mg three time a day.
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: First IVF No histoty of ovarian manipulation Lack of male infertility factor Patency of fallupian tubes No history of smoking
Exclusion criteria
Exclusion criteria: History of IVF histoty of ovarian manipulation male infertility factor No patency of fallupian tubes history of smoking
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improving fertility in patients with polycystic ovary syndrome. Timepoint: Before starting the drug from three months before the start of the IVF cycle until the puncture and then before the puncture then comparison of two drug in fertilization rate. Method of measurement: HCG, Ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Mass Index, Fertilization rate, Abortion rate, EP rate, OHSS rate, Ovum count, Ovum quality, Embryo count, , Embryo quality, Follicle count,Follicle size. Timepoint: Patients took the drug three months before the start of the IVF cycle until the puncture, Body Mass Index was measured before and after the drug was completed. Method of measurement: Body Mass Index: weight(kg) on height(cm2), Fertility: HCG and ultrasound, Abortion: HCG and ultrasound, EP: HCG and ultrasound, OHSS: ultrasound, Follicle size: ultrasound, Follicle count: ultrasound, ovum count: microscopic and embryologist, ovum quality: microscopic and embryologist, Embryo count: microscopic and embryologist, Embryo quality: microscopic and embryologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFereshteh rastegar
Tehran University of Medical Sciences
Outcome results
None listed